GLP-1 drug claims rose from 6.9% of employer plans in 2023 to 10.5% in 2025, according to Blue Cross Blue Shield data
medical head at Novo Nordisk, noted: This higher dose helps improve competitiveness while offering patients another option to reach treatment goals
Hims is a solid option for people seeking straightforward, well-understood treatments like hair-loss medication, ED drugs, or basic skin-care prescriptions
It also helps boost collagen production and supports the connective tissues in the cells, offering additional support
Abandoned by his parents at the age of two, he lived with one of his grandparents for several years before being placed in an orphanage
In addition, this activity is sequence specific as it is reduced in the S